Evidence map›Paper›PMID 28928276›Full record

ArticleRNA (New York, N.Y.)2017

Precursor microRNA-122 inhibits synthesis of

Kara L Norman, Tzu-Chun Chen, Gusti Zeiner, Peter Sarnow

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RNA (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Key events in cancer: Dysregulation of SREBPs.Frontiers in pharmacology · 2023
    Review
  3. Interaction ofTranslational breast cancer research : a journal focusing on translational research in breast cancer · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kara L NormanDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California 94305, USA.
Tzu-Chun ChenDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California 94305, USA.
Gusti ZeinerDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California 94305, USA.
Peter SarnowDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California 94305, USA.
Stanford University · US

Funding

Roles for microRNA-122 in hepatitis C virus RNA amplificationR01AI069000 · NIAID · STANFORD UNIVERSITY · PI SARNOW, PETER · 2006 to 2022
$6.2M
NIAID NIH HHS R01 AI069000
6 · The paper itself

Abstract

The insulin-induced gene 1 protein (

Indexed as

Gene Expression Regulation3' Untranslated RegionsCells, CulturedHumansIntracellular Signaling Peptides and ProteinsLiverLiver NeoplasmsMembrane ProteinsMicroRNAsPoly APolyadenylationProtein IsoformsRNA, Messenger3' Untranslated RegionsINSIG1 protein, humanIntracellular Signaling Peptides and ProteinsMembrane ProteinsMicroRNAsMIRN122 microRNA, humanPoly AProtein IsoformsRNA, MessengercholesterolInsig1microRNAmRNA isoformspolyadenylation site

Identifiers

PMID28928276
PMCPMC5689008
OpenAlexW2754341339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.